Skip to main content
Clinical Trials/NCT06101914
NCT06101914
Not yet recruiting
Not Applicable

Evaluating the Occurrence of Engagement Patterns and Participation Trends Among Patients in Treatment Resistant Depression

Power Life Sciences Inc.1 site in 1 country500 target enrollmentNovember 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Treatment Resistant Depression
Sponsor
Power Life Sciences Inc.
Enrollment
500
Locations
1
Primary Endpoint
Rate of patients who decide to enroll in a treatment resistant depression clinical research.
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Clinical studies, with a distinct focus on treatment resistant depression, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Registry
clinicaltrials.gov
Start Date
November 2024
End Date
November 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of treatment resistant depression
  • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
  • No prior treatment for treatment resistant depression

Exclusion Criteria

  • Enrolled in another research study
  • Inability to provide written informed consent
  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a treatment resistant depression clinical research.

Time Frame: 3 months

Number of treatment resistant depression study participants who remain in clinical study until completion.

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials